MET MetLife, Inc.
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.…
Industry Peers
Insurance - LifeKey Statistics
About MetLife (NYSE: MET)
›
MetLife (NYSE: MET) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Insurance - Life industry, part of the Financial Services sector, and reports about 46,000 employees.
The shares were at 97.60 USD on 19 November 2026, up 31.1% over 52 weeks. Its 52-week range is 67.33 USD to 106.72 USD: the price is 8.5% below the high and 45.0% above the low.
At a market capitalisation of 61.34B USD, it trades at 12.8 times trailing earnings and 8.7 times forward earnings. The median trailing P/E of its 19 largest Insurance - Life peers is 11.4, a premium of 12% for MET. It pays a dividend yielding 2.38% (it pays out 30% of its earnings), against a median of 2.70% among the dividend payers in that peer group.
MetLife reports return on equity of 11.9%, an operating margin of 8.5% and revenue up 18.2% year over year.
Its debt exceeds its cash by 23.16B USD, a debt-to-equity ratio of 0.71. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 16 analysts cover the stock, with an average rating of Buy; their mean price target of 111.13 USD is 13.9% above the current price. The next earnings report is expected on 10 February 2027.